Lv5
850 积分 2023-06-30 加入
Efficacy and Safety of Tezepelumab in Adults With Severe, Uncontrolled Asthma in Asia: Results From the Phase 3 DIRECTION Study
12小时前
待确认
Biologics for severe asthma—Which, when and why?
17小时前
待确认
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study
2天前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
3天前
已完结
Expression profiles of cadherin 17 and claudin 18.2 in comparison with peptide hormonal expression in pancreatic neuroendocrine tumours: Implications for targeted immunotherapy
4天前
已完结
Efficacy and safety of first-line targeted and immunotherapy for metastatic colorectal cancer: a network meta-analysis
25天前
已完结
Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018)
30天前
已完结
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial
1个月前
已完结
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
1个月前
已完结
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
1个月前
已完结
皖公网安备34019202002308